Fibrous dysplasia is a neoplasm
2001; Wiley; Volume: 98; Issue: 4 Linguagem: Inglês
10.1002/1096-8628(20010201)98
ISSN1096-8628
Autores Tópico(s)Histiocytic Disorders and Treatments
ResumoAmerican Journal of Medical GeneticsVolume 98, Issue 4 p. 290-293 Editorial Comment: Editorial Comment Fibrous dysplasia is a neoplasm M. Michael Cohen Jr. D.M.D., Ph.D., FCCMG, M. Michael Cohen Jr. D.M.D., Ph.D., FCCMG Departments of Oral and Maxillofacial Sciences, Pediatrics, Community Health and Epidemiology, Health Services Administration, and Sociology and Social Anthropology, Dalhousie University, Halifax, Nova Scotia, CanadaSearch for more papers by this author M. Michael Cohen Jr. D.M.D., Ph.D., FCCMG, M. Michael Cohen Jr. D.M.D., Ph.D., FCCMG Departments of Oral and Maxillofacial Sciences, Pediatrics, Community Health and Epidemiology, Health Services Administration, and Sociology and Social Anthropology, Dalhousie University, Halifax, Nova Scotia, CanadaSearch for more papers by this author First published: 19 January 2001 https://doi.org/10.1002/1096-8628(20010201)98:4 3.0.CO;2-FCitations: 25Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES Ballaré E, Mantovani S, Lania A, Di Biasio AM, Vallar L, Spada A. 1998. Activating mutations of the Gsα gene are associated with low levels of Gsα protein in growth hormone-secreting tumors. J Clin Endocrinol Metab 80: 1347–1351. Banat S, Shenker A, Monroe J, Reynolds JC, Merino MJ, Frierson HF Jr, Rogol AD, Bone HG III, Robey PG, Collins MT, Sarlis NJ. 2000. Papillary thyroid carcinoma (PTC) in a child with McCune-Albright syndrome (MAS): more than a random association. 82nd Annual Meeting of the Endocrine Society, Toronto, June 21–24. Cabral CE, Guedes P, Fonesca T, Rozende JF, Cruz Junior LC, Smith J. 1998. Polyostotic fibrous dysplasia associated with intramuscular myxomas: Mazabraud's syndrome. Skeletal Radiol 27: 278–282. Candeliere GA, Glorieux FH, Prud'homme J, St-Arnaud R. 1995. Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia. N Engl J Med 332: 1546–1551. Candeliere GA, Roughley PJ, Glorieux FH. 1997. Polymerase chain reaction-based technique for the selective enrichment and analysis of mosaic arg201 mutations in G alpha s from patients with fibrous dysplasia of bone. Bone 21: 201–206. Cohen MM Jr, Howell RE. 1999. Etiology of fibrous dysplasia and McCune-Albright syndrome. Int J Oral Maxillofac Surg 28: 366–371. Cohen MM Jr. 2000. Merging the old skeletal biology with the new. I. Intramembranous ossification, endochondral ossification, ectopic bone, secondary cartilage, and pathologic considerations. J Craniofac Genet Dev Biol 20: 89–93. Collins MT, Shenker A. 1999. McCune-Albright syndrome: new insights. Endocrinol Diabetes 6: 119–125. Collins MT, Shenker A, Monroe J, Krakoff JA, Merino MJ, Sarlis NJ. 1999. Clear cell thyroid carcinoma in a patient with McCune-Albright syndrome: clinical description and analysis of tumor features. 81st Annual Meeting of the Endocrine Society, San Diego, June 12–15. Faglia G, Arosio M, Spada A. 1996. GS protein mutations and pituitary tumors: functional correlates and possible therapeutic implications. Metabolism 45: (8 Suppl 1) 117–119. Fragoso MCBV, Latronico AC, Carvalho FM, Zerbini MCN, Marcondes JAM, Araujo LMB, Lano VS, Frazzatto ET, Mendonca BB, Villares SMF. 1998. Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors. J Clin Endocrinol Metab 83: 2074–2078. Hammami MM, Al-Zahrani A, Butt A, Vencer LJ, Hussain SS. 1997. Primary hyperparathyroidism-associated polyostotic fibrous dysplasia: absence of McCune-Albright syndrome mutations. J Endocrinol Invest 20: 552–558. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L. 1989. GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340: 692–696. Malchoff CD, Reardon G, MacGillivrary DC, Yamase H, Rogol AD, Malchoff DM. 1994. An unusual presentation of McCune-Albright syndrome confirmed by an activating mutation of the G(s) alpha-subunit from a bone lesion. J Clin Endocrinol Metab 78: 803–806. Marie PJ, de Pollak C, Chanson P, Lomri A. 1997. Increased proliferation of osteoblastic cells expressing the activating Gsα mutation in monostotic and polyostotic fibrous dysplasia. Am J Pathol 150: 1059–1069. Michiels FM, Caillou B, Talbot M, Dessarps-Freichey F, Maunoury MT, Schlumberger M, Mercken L, Monier R, Feunteun J. 1994. Oncogenic potential of guanine nucleotide stimulatory factor alpha subunit in thyroid glands of transgenic mice. Proc Natl Acad Sci USA 91: 10488–10492. Pienkowski C, Lumbroso S, Bieth E, Sultan C, Rochiccioli P, Tauber M. 1997. Recurrent ovarian cyst and mutation of the Gsα gene in ovarian cyst fluid cells: what is the link with McCune-Albright syndrome. Acta Paediatr 86: 1019–1021. Riminucci M, Fisher LW, Shenker A, Spiegel AM, Bianco P, Robey PG. 1997. Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation. Am J Pathol 151: 1587–1600. Russo D, Arturi F, Wicker R, Chazenbalk GD, Schlumberger M, DuVillard JAD, Caillou B, Monier R, Rapoport B, Filetti S, Suarez HG. 1995. Genetic alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab 80: 1347–1351. Ruther U, Garber C, Komitowski D, Muller R, Wagner EF. 1987. Deregulated c-fos expression interferes with normal bone development in transgenic mice. Nature 325: 412–416. Ruther U, Komitowski D, Schubert FR, Wagner EF. 1989. C-fos expression induces bone tumors in transgenic mice. Oncogene 4: 861–865. Schwartz DT, Alpert M. 1964. The malignant transformation of fibrous dyplasia. Am J Med Sci 247: 1. Schwindinger WF, Francomano CA, Levine MA. 1992. Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G-protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci USA 89: 5152–5156. Shenker A, Weinstein LS, Moran A, Pescovitz OH, Charest NJ, Boney CM, Van Wyk JJ, Merino MJ, Feuillan PP, Spiegel AM. 1993. Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein Gs. J Pediatr 123: 509–518. Shenker A, Weinstein LS, Sweet DE, Spiegel AM. 1994. An activating Gsα mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J Clin Endocrinol Metab 79: 750–755. Shenker A, Chanson P, Weinstein LS, Chi P, Spiegel AM, Lomri A, Marie PJ. 1995. Osteoblastic cells derived from isolated lesions of fibrous dysplasia contain activating somatic mutations of the G(S)-alpha gene. Hum Mol Genet 4: 1675–1676. Spambalg D, Sharifi N, Elisei R, Gross JL, Medeiros-Neto G, Fagin JA. 1996. Structural studies of the thyrotropin receptor and Gs alpha in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformation. J Clin Endocrinol Metab 81: 3898–3901. Tanner HC Jr, Dahlin DC, Childs DS Jr. 1961. Sarcoma complicating fibrous dysplasia. Probable role of radiation therapy. Oral Surg 14: 837. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. 1991. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325: 1688–1695. Williamson EA, Ince PG, Harrison D, Kendall-Taylor P, Harris PE. 1991. G-protein mutations in human pituitary adrenocorticotrophic hormone-secreting adenomas. Eur J Clin Invest 25: 128–131. Yabut SM Jr, Kenan S, Sissons HA, Lewis MM. 1988. Malignant transformations of fibrous dysplasia: a case report and review of the literature. Clin Orthop 228: 281–288. Yoshimoto K, Iwahana H, Fukuda A, Sano T, Itakura M. 1993. Rare mutations of the Gs alpha subunit gene in human endocrine tumors. Mutation detection by polymerase chain reaction-primer-introduced restriction analysis. Cancer 72: 1386–1393. Zeiger MA, Saji M, Gusev Y, Westra WH, Takiyama Y, Dooley WC, John LD, Levine MA. 1997. Thyroid-specific expression of cholera toxin A1 subunit causes thyroid hyperplasia and hyperthyroidism in transgenic mice. Endocrinology 138: 3133–3140. Citing Literature Volume98, Issue41 February 2001Pages 290-293 ReferencesRelatedInformation
Referência(s)